HRSA-25-069: Addiction Medicine Fellowship Program
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants to nonprofits, colleges and universities, tribes and businesses. It expected to make about 28 awards worth $23.1 million in total. Applications closed on February 28, 2025.
From the official notice on Grants.gov, last changed December 20, 2024. Checked November 7, 2026.
- Total funding$23.1 million
- Expected awards28
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | December 20, 2024 |
|---|---|
| Deadline | February 28, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, tribes and businesses.
All 8 applicant types the notice lists
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
You can apply if your organization is a U.S.-based sponsoring institution (or parent institution of the sponsoring institution) of an accredited addiction medicine or accredited addiction psychiatry fellowship program, or a consortium (consisting of at least one domestic teaching health center and the sponsoring institution) of a domestic addiction medicine or addiction psychiatry fellowship program. The sponsoring institution must be accredited by the Accreditation Council of Graduate Medical Education (ACGME). You must provide documentation of your ACGME accreditation in addiction medicine as Attachment 1. Types of eligible organizations If otherwise eligible, these types of domestic* organizations may apply. Public institutions of higher education Private institutions of higher education Nonprofits with or without a 501(c)(3) IRS status For-profit organizations Native American tribal governments Native American tribal organizations Individuals are not eligible applicants under this NOFO. Domestic means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of the AMF program is to expand the number of fellows at accredited addiction medicine and addiction psychiatry fellowship programs trained as addiction medicine specialists. These fellows will practice in medically underserved, community-based settings that integrate primary care with mental health disorder and substance use disorder (SUD) prevention and treatment services. The fellowship must include training in prevention and treatment services in medically underserved community-based settings, including in rural areas, that have limited or no access to SUD prevention or treatment. The AMF program trains both addiction medicine and addiction psychiatry fellows.
Who has won Mental and Behavioral Health Education and Training Grants grants before
From fiscal 2021 to 2025, Mental and Behavioral Health Education and Training Grants (93.732) awarded $770 million across 544 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of Wisconsin System | Wisconsin | 2 | $12.5 million |
| University of Utah | Utah | 5 | $9.4 million |
| University of Arizona | Arizona | 5 | $9.4 million |
| Loma Linda University | California | 5 | $7.2 million |
| The General Hospital Corporation | Massachusetts | 3 | $6.6 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-25-069 still open?
No. It closed on February 28, 2025.
Who can apply for Addiction Medicine Fellowship Program?
Health Resources and Services Administration accepted applications from nonprofits, colleges and universities, tribes and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Addiction Medicine Fellowship Program?
Closed February 28, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $23.1 million in total across about 28 awards.
Who has won Mental and Behavioral Health Education and Training Grants grants before?
The largest recipients over five fiscal years were University of Wisconsin System, University of Utah, University of Arizona. The program made 544 awards worth $770 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)